Long-Term Liabilities: The sum of all non-current liabilities.
TNF Pharmaceuticals, Inc. (QCLS) had Long-Term Liabilities of $6.32M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.77M |
|
-- |
|
-- |
|
$1.87M |
|
$-1.87M |
|
$0.08M |
|
$-1.80M |
|
$-1.80M |
|
$-1.80M |
|
$-1.80M |
|
$-1.80M |
|
$-1.80M |
|
$-1.87M |
|
$-1.87M |
|
0.16M |
|
0.16M |
|
$-18.00 |
|
$-18.00 |
|
| Balance Sheet Financials | |
$5.15M |
|
-- |
|
$12.00M |
|
$17.15M |
|
$5.55M |
|
-- |
|
|
Long-Term Liabilities |
$6.32M |
$11.87M |
|
$5.13M |
|
$-5.22M |
|
$5.28M |
|
0.29M |
|
| Cash Flow Statement Financials | |
$-4.71M |
|
$4.74M |
|
-- |
|
$0.17M |
|
$0.21M |
|
$0.03M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.99% |
|
34.40% |
|
-10.47% |
|
-34.04% |
|
$17.96 |
|
$-29.97 |
|
$-29.97 |
|